At stake in mifepristone case: abortion, FDA’s authority and return to 1873 obscenity law
By Sarah Varney
March 25, 2024 Lawyers from the conservative Christian group that won the case to overturn Roe v. Wade are returning to the U.S. Supreme Court on Tuesday in pursuit of an urgent priority: shutting down access to abortion pills for women across the country. The case challenges the FDA’s regulation of mifepristone, a prescription-only drug approved in 2000 […]